FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

763033005: Letermovir (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3637610014 Letermovir en Synonym Active Entire term case insensitive SNOMED CT core module
3637611013 Letermovir (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Letermovir Is a Heterocyclic compound false Inferred relationship Existential restriction modifier
Letermovir Has disposition Cytomegalovirus terminase complex inhibitor true Inferred relationship Existential restriction modifier
Letermovir Is a Substance with Cytomegalovirus terminase complex inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Letermovir Is a Quinazoline true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing letermovir Has active ingredient True Letermovir Inferred relationship Existential restriction modifier 1
Product containing letermovir in oral dose form (medicinal product form) Has active ingredient True Letermovir Inferred relationship Existential restriction modifier 1
Letermovir Has active ingredient True Letermovir Inferred relationship Existential restriction modifier 1
Product containing only letermovir in oral dose form (medicinal product form) Has active ingredient True Letermovir Inferred relationship Existential restriction modifier 1
Product containing precisely letermovir 480 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Letermovir Inferred relationship Existential restriction modifier 1
Product containing precisely letermovir 480 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Letermovir Inferred relationship Existential restriction modifier 1
Product containing precisely letermovir 240 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Letermovir Inferred relationship Existential restriction modifier 1
Product containing precisely letermovir 240 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Letermovir Inferred relationship Existential restriction modifier 1
Letermovir 240mg/12ml solution for infusion vials Has specific active ingredient True Letermovir Inferred relationship Existential restriction modifier
Prevymis 240mg/12ml concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has specific active ingredient True Letermovir Inferred relationship Existential restriction modifier
Letermovir 240mg/12ml solution for infusion vials 1 vial Has specific active ingredient True Letermovir Inferred relationship Existential restriction modifier
Letermovir 240mg/12ml solution for infusion vials Has active ingredient False Letermovir Inferred relationship Existential restriction modifier
Prevymis 240mg/12ml concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) 1 vial Has specific active ingredient True Letermovir Inferred relationship Existential restriction modifier
Letermovir 240mg tablets Has specific active ingredient True Letermovir Inferred relationship Existential restriction modifier
Prevymis 240mg tablets (Merck Sharp & Dohme (UK) Ltd) Has specific active ingredient True Letermovir Inferred relationship Existential restriction modifier
Letermovir 240mg tablets 28 tablet Has specific active ingredient True Letermovir Inferred relationship Existential restriction modifier
Prevymis 240mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient True Letermovir Inferred relationship Existential restriction modifier
Letermovir Has active ingredient False Letermovir Inferred relationship Existential restriction modifier
Letermovir 240mg tablets Has active ingredient False Letermovir Inferred relationship Existential restriction modifier
Prevymis 240mg tablets (Merck Sharp & Dohme (UK) Ltd) Has active ingredient True Letermovir Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start